US Stock MarketDetailed Quotes

IPHA Innate Pharma

Watchlist

2.370
0.0000.00%

Trading Apr 23 15:51 ET

191.60MMarket Cap-24687P/E (TTM)

Innate Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

(FY)Dec 31, 2016

(FY)Dec 31, 2015

(FY)Dec 31, 2014

Total revenue

4.68%51.9M

309.41%49.58M

-78.43%12.11M

-18.15%56.16M

-14.12%68.61M

144.83%79.89M

-41.90%32.63M

213.64%56.16M

1,874.20%17.91M

-92.73%907K

Operating revenue

3.37%51.89M

314.51%50.2M

-78.59%12.11M

-17.18%56.57M

-14.00%68.31M

145.53%79.42M

-42.52%32.35M

214.58%56.27M

1,872.22%17.89M

-92.73%907K

Cost of revenue

-99.21%337K

42.74M

Gross profit

886.82%79.56M

-118.00%-10.11M

213.64%56.16M

1,874.20%17.91M

-81.45%907K

Operating expense

-2.17%64.57M

10.12%66.01M

8.83%59.94M

-17.84%55.08M

-9.91%67.04M

149.10%74.41M

-38.52%29.87M

69.42%48.59M

37.39%28.68M

172.40%20.87M

Selling and administrative expenses

-18.83%11.75M

-9.49%14.47M

26.00%15.99M

-14.15%12.69M

-18.87%14.78M

-45.91%18.22M

261.07%33.68M

58.71%9.33M

22.53%5.88M

-55.03%4.8M

-Selling and marketing expense

----

132.36%1.51M

44.22%649K

56.25%450K

11.20%288K

-8.48%259K

-General and administrative expense

-18.83%11.75M

-9.49%14.47M

26.00%15.99M

-14.15%12.69M

-11.55%14.78M

-49.41%16.71M

272.06%33.04M

58.84%8.88M

23.18%5.59M

-56.30%4.54M

Research and development costs

8.44%56.02M

9.91%51.66M

-5.44%47M

-20.97%49.71M

-9.57%62.9M

2,078.36%69.56M

-93.43%3.19M

62.60%48.63M

31.91%29.91M

--22.67M

Depreciation amortization depletion

----

-84.24%693K

2,177.72%4.4M

48.46%193K

7.44%130K

-86.25%121K

-Depreciation and amortization

----

-84.24%693K

2,177.72%4.4M

48.46%193K

7.44%130K

-86.25%121K

Other operating expenses

-2,342.75%-3.2M

95.72%-131K

58.24%-3.06M

31.21%-7.32M

24.29%-10.65M

-23.31%-14.06M

-19.26%-11.4M

-32.15%-9.56M

-7.74%-7.24M

-64.14%-6.72M

Operating profit

22.87%-12.67M

65.66%-16.43M

-4,532.53%-47.83M

-31.40%1.08M

-69.43%1.57M

112.87%5.15M

-628.09%-39.98M

170.28%7.57M

46.05%-10.77M

-620.05%-19.97M

Net non-operating interest income expense

883.33%2.54M

1,620.00%258K

-93.27%15K

-84.44%223K

10.40%1.43M

20.07%1.3M

57.58%1.08M

712.50%686K

45.10%-112K

22.43%-204K

Non-operating interest income

481.87%3.18M

66.97%546K

-42.02%327K

-65.19%564K

2.40%1.62M

26.16%1.58M

--1.25M

----

Non-operating interest expense

122.22%640K

-7.69%288K

-8.50%312K

67.16%341K

100.00%204K

-9.73%102K

-8.87%113K

-10.79%124K

-15.76%139K

-14.95%165K

Total other finance cost

----

-109.34%-17K

203.33%182K

107.41%60K

-2,900.00%-810K

-169.23%-27K

-43.48%39K

Other net income (expense)

106.13%2.56M

-1,894.21%-41.81M

209.34%2.33M

-143.86%-2.13M

230.44%4.86M

59.13%-3.73M

-294.60%-9.12M

12.11%4.68M

698.85%4.18M

263.19%523K

Gain on sale of security

418.26%2.56M

-134.55%-805K

209.34%2.33M

-143.86%-2.13M

230.44%4.86M

59.13%-3.73M

-294.60%-9.12M

12.11%4.68M

486.80%4.18M

81.63%712K

Earnings from equity interest

----

22.86%-189K

Special income (charges)

--0

---41M

--0

----

--0

----

-Less:Impairment of capital assets

--0

--41M

--0

----

--0

----

Income before tax

86.94%-7.57M

-27.47%-57.97M

-5,385.89%-45.48M

-110.54%-829K

189.48%7.87M

105.66%2.72M

-471.04%-48.02M

292.98%12.94M

65.87%-6.71M

-579.36%-19.65M

Income tax

-190.49%-333K

22.26%368K

301K

Net income

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

65.87%-6.71M

-579.36%-19.65M

Net income continuous Operations

86.94%-7.57M

-27.47%-57.97M

-5,385.89%-45.48M

-110.54%-829K

158.05%7.87M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

65.87%-6.71M

-579.36%-19.65M

Net income discontinuous operations

--0

98.21%-131K

88.39%-7.33M

-120.61%-63.16M

---28.63M

----

Minority interest income

Net income attributable to the parent company

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

65.87%-6.71M

-579.36%-19.65M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

65.87%-6.71M

-579.36%-19.65M

Basic earnings per share

87.67%-0.09

-10.61%-0.73

18.52%-0.66

-161.29%-0.81

-720.00%-0.31

105.62%0.05

-486.96%-0.89

276.92%0.23

66.67%-0.13

-457.14%-0.39

Diluted earnings per share

87.67%-0.09

-10.61%-0.73

18.52%-0.66

-161.29%-0.81

-720.00%-0.31

105.62%0.05

-486.96%-0.89

276.92%0.23

66.67%-0.13

-457.14%-0.39

Dividend per share

Currency Unit

EUR

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017	(FY)Dec 31, 2016	(FY)Dec 31, 2015	(FY)Dec 31, 2014
Total revenue	4.68%51.9M	309.41%49.58M	-78.43%12.11M	-18.15%56.16M	-14.12%68.61M	144.83%79.89M	-41.90%32.63M	213.64%56.16M	1,874.20%17.91M	-92.73%907K
Operating revenue	3.37%51.89M	314.51%50.2M	-78.59%12.11M	-17.18%56.57M	-14.00%68.31M	145.53%79.42M	-42.52%32.35M	214.58%56.27M	1,872.22%17.89M	-92.73%907K
Cost of revenue						-99.21%337K	42.74M	0	0	0
Gross profit						886.82%79.56M	-118.00%-10.11M	213.64%56.16M	1,874.20%17.91M	-81.45%907K
Operating expense	-2.17%64.57M	10.12%66.01M	8.83%59.94M	-17.84%55.08M	-9.91%67.04M	149.10%74.41M	-38.52%29.87M	69.42%48.59M	37.39%28.68M	172.40%20.87M
Selling and administrative expenses	-18.83%11.75M	-9.49%14.47M	26.00%15.99M	-14.15%12.69M	-18.87%14.78M	-45.91%18.22M	261.07%33.68M	58.71%9.33M	22.53%5.88M	-55.03%4.8M
-Selling and marketing expense	----	----	----	----	----	132.36%1.51M	44.22%649K	56.25%450K	11.20%288K	-8.48%259K
-General and administrative expense	-18.83%11.75M	-9.49%14.47M	26.00%15.99M	-14.15%12.69M	-11.55%14.78M	-49.41%16.71M	272.06%33.04M	58.84%8.88M	23.18%5.59M	-56.30%4.54M
Research and development costs	8.44%56.02M	9.91%51.66M	-5.44%47M	-20.97%49.71M	-9.57%62.9M	2,078.36%69.56M	-93.43%3.19M	62.60%48.63M	31.91%29.91M	--22.67M
Depreciation amortization depletion	----	----	----	----	----	-84.24%693K	2,177.72%4.4M	48.46%193K	7.44%130K	-86.25%121K
-Depreciation and amortization	----	----	----	----	----	-84.24%693K	2,177.72%4.4M	48.46%193K	7.44%130K	-86.25%121K
Other operating expenses	-2,342.75%-3.2M	95.72%-131K	58.24%-3.06M	31.21%-7.32M	24.29%-10.65M	-23.31%-14.06M	-19.26%-11.4M	-32.15%-9.56M	-7.74%-7.24M	-64.14%-6.72M
Operating profit	22.87%-12.67M	65.66%-16.43M	-4,532.53%-47.83M	-31.40%1.08M	-69.43%1.57M	112.87%5.15M	-628.09%-39.98M	170.28%7.57M	46.05%-10.77M	-620.05%-19.97M
Net non-operating interest income expense	883.33%2.54M	1,620.00%258K	-93.27%15K	-84.44%223K	10.40%1.43M	20.07%1.3M	57.58%1.08M	712.50%686K	45.10%-112K	22.43%-204K
Non-operating interest income	481.87%3.18M	66.97%546K	-42.02%327K	-65.19%564K	2.40%1.62M	26.16%1.58M	--1.25M	----	----	----
Non-operating interest expense	122.22%640K	-7.69%288K	-8.50%312K	67.16%341K	100.00%204K	-9.73%102K	-8.87%113K	-10.79%124K	-15.76%139K	-14.95%165K
Total other finance cost	----	----	----	----	-109.34%-17K	203.33%182K	107.41%60K	-2,900.00%-810K	-169.23%-27K	-43.48%39K
Other net income (expense)	106.13%2.56M	-1,894.21%-41.81M	209.34%2.33M	-143.86%-2.13M	230.44%4.86M	59.13%-3.73M	-294.60%-9.12M	12.11%4.68M	698.85%4.18M	263.19%523K
Gain on sale of security	418.26%2.56M	-134.55%-805K	209.34%2.33M	-143.86%-2.13M	230.44%4.86M	59.13%-3.73M	-294.60%-9.12M	12.11%4.68M	486.80%4.18M	81.63%712K
Earnings from equity interest	----	----	----	----	----	----	----	----	----	22.86%-189K
Special income (charges)	--0	---41M	--0	--0	----	--0	----	----	----	----
-Less:Impairment of capital assets	--0	--41M	--0	--0	----	--0	----	----	----	----
Income before tax	86.94%-7.57M	-27.47%-57.97M	-5,385.89%-45.48M	-110.54%-829K	189.48%7.87M	105.66%2.72M	-471.04%-48.02M	292.98%12.94M	65.87%-6.71M	-579.36%-19.65M
Income tax	0	0	0	0	0	-190.49%-333K	22.26%368K	301K	0	0
Net income	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M	65.87%-6.71M	-579.36%-19.65M
Net income continuous Operations	86.94%-7.57M	-27.47%-57.97M	-5,385.89%-45.48M	-110.54%-829K	158.05%7.87M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M	65.87%-6.71M	-579.36%-19.65M
Net income discontinuous operations	--0	98.21%-131K	88.39%-7.33M	-120.61%-63.16M	---28.63M	----	----	----	----	----
Minority interest income
Net income attributable to the parent company	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M	65.87%-6.71M	-579.36%-19.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M	65.87%-6.71M	-579.36%-19.65M
Basic earnings per share	87.67%-0.09	-10.61%-0.73	18.52%-0.66	-161.29%-0.81	-720.00%-0.31	105.62%0.05	-486.96%-0.89	276.92%0.23	66.67%-0.13	-457.14%-0.39
Diluted earnings per share	87.67%-0.09	-10.61%-0.73	18.52%-0.66	-161.29%-0.81	-720.00%-0.31	105.62%0.05	-486.96%-0.89	276.92%0.23	66.67%-0.13	-457.14%-0.39
Dividend per share
Currency Unit	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall